Preclinical Evaluation of a ⁶⁴Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma

Although the concept of theranostics is neither new nor exclusive to nuclear medicine, it is a particularly promising approach for the future of nuclear oncology. This approach is based on the use of molecules targeting specific biomarkers in the tumour or its microenvironment, associated with optim...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O. Hofgaard, Bjarne Bogen, Julie Pineau, Nathalie Le Bris, Raphaël Tripier, Cyrille Alliot, Férid Haddad, Michel Chérel, Nicolas Chouin, Alain Faivre-Chauvet, Latifa Rbah-Vidal
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-06-01
Col·lecció:	Pharmaceutics
Matèries:	theranostics copper-64 PET imaging targeted radionuclide therapy dosimetry CD138
Accés en línia:	https://www.mdpi.com/1999-4923/15/7/1817
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!